Glycosphingolipid Structures

Comprehensive Glycoscience: From Chemistry to Systems Biology

Volumn 1-4, Issue , 2007, Pages 73-122

  Yu, R K ^a   Yanagisawa, M ^a   Ariga, T ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014129365     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451967-2/00003-9     Document Type: Chapter

References (366)

1. Ariga T., Yu R.K. Antiglycolipid antibodies in Guillain-Barre syndrome and related diseases: Review of clinical features and antibody specificities. J. Neurosci. Res. 2005, 80:1-17.
2. Hakomori S.-I. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization. Glycoconj. J. 2004, 21:125-137.
3. Honma K., Manabe H., Tomita M., Hamada A. Isolation and partial structural characterization of macroglycolipid from rabbit erythrocyte membranes. J. Biochem. 1981, 90:1187-1196.
4. The nomenclature of lipids. Lipids 1977, 12:455-468. IUPAC-IUB Commission on Biochemical Nomenclature.
5. Nomenclature of Glycolipids, International Union of Pure and Applied Chemistry Website. http://www.chem.qmul.ac.uk/iupac.
6. Ganglioside abbreviations are based on that of Svennerholm, L. Chromatographic seperation of human brain ganglioside. J. Neurochem. 1963, 10:613-623.
7. Iwabuchi K., Yamamura S., Prinetti A., Handa K., Hakomori S.-I. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J. Biol. Chem. 1998, 273:9130-9138.
8. Koscielak J., Miller-Podraza H., Krauze R., Piasek A. Isolation and characterization of poly(glycosyl)ceramides (megaloglycolipids) with A, H and I blood-group activities. Eur. J. Biochem. 1976, 71:9-18.
9. Yu R.K., Bieberich E., Xia T., Zeng G. Regulation of ganglioside biosynthesis in the nervous system. J. Lipid Res. 2004, 45:783-793.
10. Zdebska E., Koscielak J. Studies on the structure and I-blood-group activity of poly(glycosyl)ceramides. Eur. J. Biochem. 1978, 91:517-525.
11. Abe K., McKibbin J.M., Hakomori S.-I. The monoclonal antibody directed to difucosylated type 2 chain (Fucα1-2Galβ1-4[Fucα1-3]GlcNAc; Y determinant). J. Biol. Chem. 1983, 258:11793-11797.
12. Abe K., Levery S.B., Hakomori S.-I. The antibody specific to type 1 chain blood group A determinant. J. Immunol. 1984, 132:1951-1954.
13. Ando S., Kon K., Isobe M., Nagai Y., Yamakawa T. Existence of glucosaminyl lactosyl ceramide (amino CTH-I) in human erythrocyte membranes as possible precursor of blood group-active glycolipids. J. Biochem. 1976, 79:625-632.
14. Ando S., Isobe M., Nagai Y. High performance preparative column chromatography of lipids using a new porous silica, Iatrobeads. I. Separation of molecular species of sphingoglycolipids. Biochim. Biophys. Acta. 1976, 424:98-105.
15. Ando S., Kon K., Nagai Y., Yamakawa T. A novel pentaglycosyl ceramide containing di-β-N-acetylgalactos-aminyl residue (Para-Forssman glycolipid) isolated from human erythrocyte membrane. Adv. Exp. Med. Biol. 1982, 152:71-81.
16. Angstrom J., Breimer M.E., Falk K.E., Hansson G.C., Karlsson K.A., Leffler H. Chemical characterization of penta-, hexa-, hepta-, octa-, and nonaglycosylceramides of rat small intestine having a globoside-like terminus. J. Biol. Chem. 1982, 257:682-688.
17. Angstrom J., Falk P., Hansson G.C., Holgersson J., Karlsson H., Karlsson K.A., Stromberg N., Thurin J. The mono- and difucosyl blood group B glycosphingolipids of rat large intestine differ in type of core saccharide. Biochim. Biophys. Acta 1987, 926:79-86.
18. Ariga T., Yu R.K., Scarsdale J.N., Suzuki M., Kuroda Y., Kitagawa H., Miyatake T. Accumulation of a globo-series glycolipid having Galα1-3Gal in PC12h pheochromocytoma cells. Biochemistry 1988, 27:5335-5340.
19. Ariga T., Suzuki M., Yu R.K., Kuroda Y., Shimada I., Inagaki F., Miyatake T. Accumulation of unique globo-series glycolipids in PC12h pheochromocytoma cells. J. Biol. Chem. 1989, 264:1516-1521.
20. x glycolipids. J. Biol. Chem. 1994, 269:2667-2675.
21. X glycolipids and GD1a ganglioside in human glioma cells. Glycoconj. J. 1996, 13:135-145.
22. Ariga T., Kasai N., Miyoshi I., Yamawaki M., Scarsdale J.N., Yu R.K., Kasama T., Taki T. Accumulation of isogloboside and ganglio-N-teraosyl ceramide having blood group B determinant in the hepatomas of female LEC rats. Biochim. Biophys. Acta 1995, 1254:257-266.
23. Asfaw B., Ledvinova J., Dobrovolny R., Bakker H.D., Desnick R.J., van Diggelen O.P., de Jong J.G., Kanzaki T., Chabas A., Maire I., Conzelmann E., Schindler D. Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry disease. J. Lipid Res. 2002, 43:1096-1104.
24. Berg G., Schachner M. Immunoelectron microscopic characterization of galactocerebroside and nervous system antigen-1 (NS-1) positive oligodendrocytes in culture. Neurosci. Lett. 1982, 28:75-80.
25. Blomberg J., Breimer M.E., Karlsson K.A. Glycosphingolipids of a green monkey kidney cell line (GMK AH-1). Evidence for a novel pentaglycosylceramide based on globotetraosylceramide. Biochim. Biophys. Acta 1982, 711:466-477.
26. Bouhours D., Angstrom J., Jovall P.-A., Hansson G.C., Bouhours J.-F. Characterization of a novel A-active octaglycosylceramide with type 1 chain repeat inherited as a recessive trait in the epithelial cells of the small intestine of inbred rats. J. Biol. Chem. 1991, 266:18613-18619.
27. x hexaglycosylceramide. Glycoconj. J. 1997, 14:29-38.
28. 4-β-Gal-nLc4Cer, with terminal Gal(β1-4)Gal, a xenoepitope recognized by human natural antibodies. Glycobiology 2000, 10:857-864.
29. Breimer M.E., Hansson G.C., Karlsson K.A., Leffler H. Glycolipids of rat small intestine. Characterization of a novel blood group H-active triglycosylceramide. Biochim. Biophys. Acta. 1980, 617:85-96.
30. Breimer M.E., Karlsson K.A., Samuelsson B.E. Characterization of a blood group H type pentaglycosylceramide of human pancreas based on a type 1 carbohydrate chain. J. Biol. Chem. 1981, 256:3810-3816.
31. Breimer M.E., Hansson G.C., Karlsson K.A., Leffler H. Isolation and partial characterization of blood group A and H active glycosphingolipids of rat small intestine. J. Biol. Chem. 1982, 257:906-912.
32. Breimer M.E., Hansson G.C., Karlsson K.A., Leffler H. Glycosphingolipids of rat tissues. J. Biol. Chem. 1982, 257:557-568.
33. Breimer M.E., Karlsson K.A., Samuelsson B.E. Characterization of a human intestinal difucosyl heptaglycosylceramide with a blood group B determinant and a type 1 carbohydrate chain. J. Biol. Chem. 1982, 257:1079-1085.
34. Breimer M.E., Falk K.E., Hansson G.C., Karlsson K.A. Structural identification of two ten-sugar branched chain glycosphingolipids of blood group H type present in epithelial cells of rat small intestine. J. Biol. Chem. 1982, 257:50-59.
35. Breimer M.E., Karlsson K.A., Larson G., McKibbin J.M. Chemical characterization of a blood group H type pentaglycosylceramide of human small intestine. Chem. Phys. Lipids. 1983, 33:135-144.
36. Bremer E.G., Levery S.B., Sonnino S., Ghidoni R., Canevari S., Kannagi R., Hakomori S.-I. Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J. Biol. Chem. 1984, 259:14773-14777.
37. Breimer M.E., Karlsson H., Karlsson K.A., Nilson K., Samuelsson B.E., Stromberg N. Structures of the eight- to nine-sugar glycolipids of human blood group A erythrocytes. Carbohydr. Res. 1988, 178:111-120.
38. b blood group antigen. J. Biol. Chem. 1981, 256:13223-13225.
39. Clausen H., Watanabe K., Kannagi R., Levery S.B., Nudelman E., Arao-Tomono Y., Hakomori S.-I. Blood group A glycolipid (Ax) with globo-series structure which is specific for blood group A1 erythrocytes: One of the chemical bases for A1 and A2 distinction. Biochem. Biophys. Res. Commun. 1984, 124:523-529.
40. Clausen H., Levery S.B., McKibbin J.M., Hakomori S.-I. Blood group A determinants with mono- and difucosyl type 1 chain in human erythrocyte membranes. Biochemistry 1985, 24:3578-3586.
41. y). Biochemistry 1985, 24:6190-6194.
42. Clausen H., Levery S.B., Nudelman E., Tsuchiya S., Hakomori S.-I. Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: Chemical basis of qualitative A1 and A2 distinction. Proc. Natl. Acad. Sci. USA. 1985, 82:1199-1203.
43. Clausen H., Levery S.B., Kannagi R., Hakomori S.-I. Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. J. Biol. Chem. 1986, 261:1380-1387.
44. Clausen H., Levery S.B., Nudelman E., Baldwin M., Hakomori S.-I. Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes. Biochemistry 1986, 25:7075-7085.
45. Clausen H., Levery S.B., Nudelman E.D., Stroud M., Salyan M.E.K., Hakomori S.-I. Isolation and characterization of novel glycolipids with blood group A-related structures: Galactosyl-A and sialosylgalactosyl-A. J. Biol. Chem. 1987, 262:14228-14234.
46. Dasgupta S., van Halbeek H., Hogan E.L. Ganglio-N-tetraosylceramide (GA1) of bovine and human brain: Molecular characterization and presence in myelin. FEBS Lett. 1992, 301:141-144.
47. Dasgupta S., Hogan E.L., van Halbeek H. Chemical and immunological characterization of galactosyl-β1-3-globoside in bovine, human, and rat brain. J. Neurochem. 1995, 65:2344-2349.
48. 4GalNAcGgOse4Cer: A naturally occurring novel neutral glycosphingolipid in bovine brain. Glycobiology 2000, 10:1-9.
49. Dasgupta S., Levery S.B., Hogan E. 3-O-acetyl-sphingosine-series myelin glycolipids: Characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J. Lipid Res. 2002, 43:751-761.
50. DeGrandis S., Law H., Brunton J., Gyles C., Lingwood C.A. Globotetraosylceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 1989, 264:12520-12525.
51. Duk M., Reinhold B.B., Reinhold V.N., Kusnierz-Alejska G., Lisowska E. Structure of a neutral glycosphingolipid recognized by human antibodies in polyagglutinable erythrocytes from the rare NOR phenotype. J. Biol. Chem. 2001, 276:40574-40582.
52. dH) blood-group active and related glycosphingolipids from human plasma. Arch. Biochem. Biophys. 1981, 210:396-404.
53. Egge H., Kordowicz M., Peter-Katalinic J., Hanfland P. Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids. J. Biol. Chem. 1985, 260:4927-4935.
54. Eto T., Ichikawa Y., Nishimura K., Ando S., Yamakawa T. Chemistry of lipid of the posthemolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit. J. Biochem. 1968, 64:205-213.
55. Falk P., Holgersson J., Jovall P.A., Karlsson K.A., Stromberg N., Thurin J., Brodin T., Sjogren H.O. An antigen present in rat adenocarcinoma and normal colon non-epithelial stroma is a novel Forssman-like glycolipid based on isoglobotetraosylceramide. Biochim. Biophys. Acta 1986, 878:296-299.
56. Fenderson B.A., Andrews P.W., Nudelman E., Clausen H., Hakomori S.-I. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 1987, 122:21-34.
57. Fukuda M.N., Hakomori S.-I. Structures of branched blood group A-active glycosphingolipids in human erythrocytes and polymorphism of A- and H-glycolipids in A1 and A2 subgroups. J. Biol. Chem. 1982, 257:446-455.
58. Fukuda M.N., Dell A., Oates J.E., Wu P., Klock J.C., Fukuda M. Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. J. Biol. Chem. 1985, 260:1067-1082.
59. Fukushi Y., Hakomori S.-I., Nudelman E., Cochran N. Novel fucolipids accumulating in human adenocaricinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J. Biol. Chem. 1984, 259:4681-4685.
60. Gahmberg C.G., Hakomori S.-I. Surface carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and specific ceramide tetrasaccharide for transformants. J. Biol. Chem. 1975, 250:2438-2446.
61. Gardas A. A structural study of a macro-glycolipid containing 22 sugars isolated from human erythrocytes. Eur. J. Biochem. 1976, 68:177-183.
62. Gray G.M., White R.J., Majer J.R. 1-(3′-O-Acyl)-β-glucosyl-N-dihydroxypentatriacontadienoylsphingosine, a major component of the glucosylceramides of pig and human epidermis. Biochim. Biophys. Acta 1978, 528:127-137.
63. b-glycolipids in human tumor tissue. Biochim. Biophys. Acta 1970, 202:225-228.
64. Hakomori S.-I., Stellner K., Watanabe K. Four antigenic variants of blood group A glycolipid: Examples of highly complex, branched chain glycolipid of animal cell membrane. Biochem. Biophys. Res. Commun. 1972, 49:1061-1068.
65. Hakomori S.-I. Philip Levine Award Lecture: Blood group glycolipid antigens and their modifications as human cancer antigens. Am. J. Clin. Pathol. 1984, 82:635-648.
66. Hakomori S.-I., Nudelman E., Levery S.B., Kannagi R. Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J. Biol. Chem. 1984, 259:4672-4680.
67. Hakomori S.-I., Clausen H., Levery S.B. A new series of blood group A and H antigens expressed in human erythrocytes and the incompatible A antigens expressed in tumors of blood group O and B individuals. Biochem. Soc. Trans. 1987, 15:593-596.
68. Hanada E., Handa S., Konno K., Yamakawa T. Characterization of glycolipids from rat granuloma and macrophage. J. Biochem. 1978, 83:85-90.
69. Handa S., Ariga T., Miyatake T., Yamakawa T. Presence of α-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease. J. Biochem. 1971, 69:625-627.
70. Hanfland P. Characterization of B and H blood-group active glycosphingolopids from human B erythrocyte membranes. Chem. Phys. Lipids. 1975, 15:105-124.
71. Hanfland P., Egge H. Mass spectrometric analysis of permethylated glycosphingolipids I. Sequence analysis of two blood-group B active glycosphingolipids from human B erythrocyte membranes. Chem. Phys. Lipids. 1975, 15:243-247.
72. Hanfland P., Egge H., Dabrowski U., Kuhn S., Roelcke D., Dabrowski J. Isolation and characterization of an I-active ceramide decasaccharide from rabbit erythrocyte membranes. Biochemistry 1981, 20:5310-5319.
73. Hanfland P., Kordowicz M., Niermann H., Egge H., Dabrowski U., Peter-Katalinic J., Dabrowski J. Purification and structures of branched blood-group-B-active glycosphingolipids from human erythrocyte membranes. Eur. J. Biochem. 1984, 145:531-542.
74. Hanfland P., Kordowicz M., Peter-Katalinic J., Egge H., Dabrowski J., Dabrowski U. Structure elucidation of blood group B-like and I-active ceramide eicosa- and pentacosasaccharides from rabbit erythrocyte membranes by combined gas chromatography-mass spectrometry; electron-impact and fast-atom-bombardment mass spectrometry; and two-dimensional correlated, relayed-coherence transfer, and nuclear Overhauser effect 500-MHz 1H-N.M.R. spectroscopy. Carbohydr. Res. 1988, 178:1-12.
75. Hansson G.C., Karlsson K.A., Thurin J. Glycolipids of rat large intestine. Characterization of a novel blood group B-active tetraglycosylceramide absent from small intestine. Biochim. Biophys. Acta 1980, 620:270-280.
76. Hansson G.C. The structure of two blood group A-active glycosphingolipids with 12 sugars and a branched chain present in the epithelial cells of rat small intestine. J. Biol. Chem. 1983, 258:9612-9615.
77. Hansson G.C., Bouhours J.-F., Angstrom J. Characterization of neutral blood group B-active glycosphingolipids. J. Biol. Chem. 1987, 262:13135-13141.
78. Hildebrand J., Stryckmans P., Stoffyn P. Neutral glycolipids in leukemic and nonleukemic leukocytes. J. Lipid Res. 1971, 12:361-366.
79. Hikita T., Tadano-Aritomi K., Iida-Tanaka N., Levery S.B., Ishizuka I., Hakomori S.-I. Cationic glycosphingolipids in neuronal tissues and their possible biological significance. Neurochem. Res. 2002, 27:575-581.
80. Hikita T., Tadano-Aritomi K., Iida-Tanaka N., Ishizuka I., Hakomori S.-I. De-N-acetyllactotriaosylceramideas a novel cationic glycosphingolipid of bovine brain white matter: Isolation and characterization. Biochemistry 2005, 44:9555-9562.
81. Holgersson J., Backer A.E., Breimer M.E., Gustavsson M.L., Jovall P.A., Karlsson H., Pimlott W., Samuelsson B.E. The blood group B type-4 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys. Structural and in vitro biosynthetic studies. Biochim. Biophys. Acta. 1992, 1180:33-43.
82. Hu J., Stults C.L., Holmes E.H., Macher B.A. Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: Differential expression in human leukemia cells. Glycobiology 1994, 4:251-257.
83. Kannagi R., Fukuda M.N., Hakomori S.-I. A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (Globoside). J. Biol. Chem. 1982, 257:4438-4442.
84. Kannagi R., Nudelman E., Levery S.B., Hakomori S.-I. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. J. Biol. Chem. 1982, 257:14865-14874.
85. Kannagi R., Levery S.B., Ishigami F., Hakomori S.-I., Shevinsky L.H., Knowles B.B., Solter D. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J. Biol. Chem. 1983, 258:8934-8942.
86. Kannagi R., Levery S.B., Hakomori S.-I. Hybrid type glycolipids (Lacto-Ganglio series) with a novel branched structure. J. Biol. Chem. 1984, 259:8444-8451.
87. y) determinants in human blood cell membranes (ghosts). Evidence that type 2 chain can elongate repetitively but type 1 chain cannot. J. Biol. Chem. 1985, 260:6410-6415.
88. Karlsson K.A., Samuelsson B.E., Steen G.O. Identification of a xylose-containing cerebroside in the salt gland of the herring gull. J. Lipid Res. 1972, 13:169-176.
89. Karlsson K.A., Larson G. Structural characterization of lactotetraosylceramide, a novel glycosphingolipid isolated from human meconium. J. Biol. Chem. 1979, 254:9311-9316.
90. a-b+) secretor. J. Biol. Chem. 1981, 256:3512-3524.
91. Klenk E., Rennkamp F. Ganglioside and cerebroside of cattle spleen. Hoppe Seylers Z. Physiol. Chem. 1942, 273:253-268.
92. Klenk E., Lohr J.P. On the ester cerebrosides of brain. Hoppe Seylers Z. Physiol. Chem. 1967, 348:1712-1714.
93. Kobayashi T., Goto I., Okada S., Orii T., Ohno K., Nakano T. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses. J. Neurochem. 1992, 59:1452-1458.
94. Kochetkov N.K., Zhukova I.G., Glukhoded I.S. Sphingoplasmalogens. A new type of sphingolipids. Biochim. Biophys. Acta 1963, 70:716-719.
95. Koscielak J., Plasek A., Gorniak H., Gardas A., Gregor A. Structures of fucose-containing glycolipids with H and B blood-group activity and of sialic acid and glucosamine-containing glycolipid of human-erythrocyte membrane. Eur. J. Biochem. 1973, 37:214-225.
96. Kushi Y., Ogura K., Rokukawa C., Handa S. Blood group A-active glycosphingolipids analysis by the combination of TLC-immunostaining assay and TLC/SIMS mass spectrometry. J. Biochem. 1990, 107:685-688.
97. Kushi Y., Tsunoda A., Komatsuzaki A., Watanabe K., Kasama T., Handa S. Characterization of blood-group-ABO(H)-active glycosphingolipids in type-AB human erythrocytes. Eur. J. Biochem. 1995, 231:862-867.
98. Kusunoki S., Tsuji S., Nagai Y. Ganglio-N-tetraosyl ceramide (asialo-GM1), an antigen common to the brain and immune system; its localization in myelin. Brain Res. 1985, 334:117-124.
99. Laine R., Sweeley C.C., Li Y.T., Kisic A., Rapport M.M. On the structure of cytolipin R, a ceramide tetrahexoside hapten from rat lymphosarcoma. J. Lipid Res. 1972, 13:519-524.
100. Larson G. Globoseries glycosphingolipids of human meconium. Arch. Biochem. Biophys. 1986, 246:531-545.
101. Levery S.B., Nudelman E.D., Andersen N.H., Hakomori S.-I. 1H NMR analysis of glycolipids possessing mono- and multi-meric X and Y haptens: Characterization of two novel extended Y structures from human adenocarcinoma. Carbohydr. Res. 1986, 151:311-328.
102. Levery S.B., Holmes E.H., Harris D.D., Hakomori S.-I. 1H NMR studies of a biosynthetic lacto-ganglio hybrid glycosphingolipid: Conformation of structure, interpretation of 'anomalous' chemical shifts, and evidence for interresidue amide-amide hydrogen bonding. Biochemistry 1992, 31:1069-1080.
103. Makita A., Yamakawa T. Biochemistry of organ glycolipid. I. Ceramide-oligohexosides of human, equine and bovine spleens. J. Biochem. 1962, 51:124-133.
104. Makita A., Yamakawa T. The glycolipids of the brain of Tay-Sachs' disease - the chemical structures of a globoside and main ganglioside. Jpn. J. Exp. Med. 1963, 33:361-368.
105. Makita A., Suzuki C., Yosizawa Z., Konno T. Glycolipids isolated from the spleen of Gaucher's disease. Tohoku J. Exp. Med. 1966, 88:277-288.
106. Martensson S., Due C., Pahlsson P., Nilsson B., Eriksson H., Zopf D., Olsson L., Lundblad A. A carbohydrate epitope associated with human squamous lung cancer. Cancer Res. 1988, 48:2125-2131.
107. Mapes C.A., Sweeley C.C. Galactosyl (α1-4)galactosylceramide: Galactosyl hydrolase activity in normal and Fabry plasma. Biochem. Biophys. Res. Commun. 1973, 53:1317-1324.
108. McKibbin J.M., Spencer W.A., Smith E.L., Mansson J.E., Karlsson K.A., Samuelsson B.E., Li Y.T., Li S.C. Lewis blood group fucolipids and their isomers from human and canine intestine. J. Biol. Chem. 1982, 257:755-760.
109. Miyatake T., Ariga T. Sphingoglycolipids in the nervous system in Fabry's disease. J. Neurochem. 1972, 19:1911-1916.
110. Miyatake T., Suzuki K. Globoid cell leukodystrophy: Additional deficiency of psychosine galactosidase. Biochem. Biophys. Res. Commun. 1972, 48:539-543.
111. Naiki M., Fong J., Ledeen R., Marcus D.M. Structure of the human erythrocyte blood group P1 glycosphingolipid. Biochemistry 1975, 14:4831-4837.
112. Nilsson O., Svennerholm L. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 1982, 39:709-718.
113. Nomura K., Nakajo N., Hidari K.I., Nomura H., Murata M., Suzuki M., Yamana K., Hirabayashi Y. Occurrence of a novel fucose-containing pentaglycosylceramide with blood-group B active determinant in Xenopus blastula cells: Its possible involvement in cell-cell adhesion. Biochem. J. 1995, 306:821-827.
114. Nudelman E., Kannagi R., Hakomori S.-I., Parsons M., Lipinski M., Wiels J., Fellous M., Tursz T. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 1983, 220:509-511.
115. 2FucnLc6). J. Biol. Chem. 1986, 261:11247-11253.
116. Nudelman E.D., Levery S.B., Stroud M.R., Salyan M.E., Abe K., Hakomori S.-I. A novel tumor-associated, developmentally regulated glycolipid antigen defined by monoclonal antibody ACFH-18. J. Biol. Chem. 1988, 263:13942-13951.
117. Nudelman E.D., Mandel U., Levery S.B., Kaizu T., Hakomori S.-I. A series of disialogangliosides with binary 2-3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens. J. Biol. Chem. 1989, 264:18719-18725.
118. Nudelman E.D., Levery S.B., Igarashi Y., Hakomori S.-I. Plasmalopsychosine, a novel plasmal (fatty aldehyde) conjugate of psychosine with cyclic actual linkage. J. Biol. Chem. 1992, 167:11007-11016.
119. Okada Y., Kannagi R., Levery S.B., Hakomori S.-I. Glycolipid antigens with blood group I and i specificities from human adult and umbilical cord erythrocytes. J. Immunol. 1984, 133:835-842.
120. Ostrander G.K., Levery S.B., Eaton H.L., Salyan M.E., Hakomori S.-I., Holmes E.H. Isolation and characterization of four major neutral glycosphingolipids from the liver of the English sole (Parophrys vetulus). J. Biol. Chem. 1988, 263:18716-18725.
121. Rapport M.M., Graf L., Autilio L.A., Norton W.T. Immunochemical studies of organ and tumour lipids. XIV. Galactocerebroside determinants in the myelin sheath of the central nervous system. J. Neurochem. 1964, 11:855-864.
122. Sekine M., Suzuki M., Inagaki F., Suzuki A., Yamakawa T. A new extended globoglycolipid carrying the stage specific embryonic antigen-1 (SSEA-1) determinant in mouse kidney. J. Biochem. 1987, 101:553-562.
123. Siddiqui B., Hakomori S.-I. A revised structure for the Forssman glycolipid hapten. J. Biol. Chem. 1971, 246:5766-5769.
124. Slomiany B.L., Slomiany A., Horowitz M.I. Blood group A active ceramide hexasaccharide lacking N-acetylglucosamine isolated from hog stomach mucosa. Biochim. Biophys. Acta. 1973, 326:224-231.
125. Slomiany B.L., Slomiany A., Horowitz M.I. Characterization of blood-group-H-active ceramide tetrasaccharide from hog-stomach mucosa. Eur. J. Biochem. 1974, 43:161-165.
126. Slomiany A., Slomiany B.L., Horowitz M.I. Structural study of the blood group A active glycolipids of hog gastric mucosa. J. Biol. Chem. 1974, 249:1225-1230.
127. Slomiany B.L., Slomiany A., Horowitz M.I. Characterization of three new fucolipids from hog gastric mucosa. Eur. J. Biochem. 1975, 56:353-358.
128. Slomiany B.L., Slomiany A. Blood group A active difucosyl glycolipid from hog gastric mucosa. Biochim. Biophys. Acta. 1975, 388:135-145.
129. Slomiany B.L., Slomiany A. Water-soluble glycosphingolipids of dog gastric mucosa. Characterization of a branched ceramide heptasaccharide. Eur. J. Biochem. 1977, 76:491-498.
130. Slomiany B.L., Slomiany A. Branched blood group A-active fucolipids of hog gastric mucosa. Biochim. Biophys. Acta 1977, 486:531-540.
131. Slomiany B.L., Slomiany A. Structural studies on branched fucosphingolipids of hog gastric mucosa. Chem. Phys. Lipids 1977, 20:57-69.
132. Slomiany B.L., Slomiany A. Forssman glycolipid variants of dog gastric mucosa. Structure of a branched ceramide octasaccharide. Eur. J. Biochem. 1978, 83:105-111.
133. Slomiany B.L., Slomiany A. Blood-group-(A + H) complex fucolipids of hog gastric mucosa. Eur. J. Biochem. 1978, 90:39-49.
134. Slomiany A., Slomiany B.L. Structure of the ceramide octadekahexoside isolated from gastric mucosa. Biochem. Biophys. Res. Commun. 1980, 93:770-775.
135. Slomiany B.L., Slomiany A., Galicki N.I., Kojima K. Complex fucolipids of hog gastric mucosa. Structure of the ceramide eikosahexoside. Eur. J. Biochem. 1980, 113:27-32.
136. Smith E.L., McKibbin J.M., Karlsson K.A., Pascher I., Samuelsson B.E., Li S.-C. Characterization of dog small intestine fucolipids with human blood group H activity. Biochemistry 1975, 14:3370-3376.
137. Stellner K., Saito H., Hakomori S.-I. Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and Forssman antigen. Arch. Bichem. Biophys. 1973, 155:464-472.
138. Stellner K., Hakomori S.-I. A ceramide pentasaccharide of human erythrocyte membrane. J. Biol. Chem. 1974, 249:1022-1025.
139. 4Fuc2Lc6) as human tumor-associated antigen. J. Biol. Chem. 1991, 266:8439-8446.
140. 2Fuc3Lc6). Eur. J. Biochem. 1992, 203:577-586.
141. 3FucnLc4 defined by monoclonal antibody 43-9F: Enzymatic synthesis, structural characterization, and comparative reactivity with various antibodies. Biochemistry 1994, 33:10672-10680.
142. Suetake K., Gasa S., Taki T., Chiba M., Yamaki T., Ibayashi Y., Hashi K. Human blood group B-active ganglio-glycosphingolipid in rat glioma. Biochim. Biophys. Acta 1993, 1170:25-31.
143. Sundsmo J.S., Hakomori S.-I. Lacto-N-neotetraosylceramide ('paragloboside') as a possible tumor-associated surface antigen of hamster NILPY tumor. Bichem. Biophys. Res. Commun. 1976, 68:799-806.
144. Sung S.S., Esselman W.J., Sweeley C.C. Structure of a pentahexosylceramide (Forssman Hapten) from canine intestine and kidney. J. Biol. Chem. 1973, 248:6528-6533.
145. Sung S.S., Sweeley C.C. The structure of canine intestinal trihexosylceramide. Biochim. Biophys. Acta 1979, 575:295-298.
146. Suzuki K. Glucosylceramide and related compounds in normal tissues and in Gaucher disease. Prog. Clin. Biol. Res. 1982, 95:219-230.
147. Taki T., Hirabayashi Y., Matsumoto M., Kojima K. Enzymic synthesis of a new type of fucose-containing glycolipid with fucosyltransferase of rat ascites hepatoma cell, AH 7974F. Biochim. Biophys. Acta 1979, 572:105-112.
148. Taki T., Kimura H., Gasa S., Nakamura M., Matsumoto M. A new type of blood group B active glycosphingolipid in rat bone marrow cells. Occurrence of the glycolipid in rat immunocytes and ascites hepatoma. J. Biol. Chem. 1985, 260:6219-6225.
149. Tamai Y., Nakamura K., Takayama-Abe K., Uchida K., Kasama T., Kobatake H. Less polar glycolipids in Alaskan pollack brain: Isolation and characterization of acyl galactosyl diacylglycerol, acyl galactosyl ceramide, and acylglucosyl ceramide. J. Lipid. Res. 1993, 34:601-608.
150. Teneberg S., Jovall P.A., Karlsson H., Sjogren H.O., Brodin T. Isolation and characterization of a rat testis glycosphingolipid based on gangliotetraosylceramide and having a blood group B determinant extended with β3-linked N-acetylgalactosamine. J. Biochem. 1994, 116:697-703.
151. Thudichum J.L.W. A Treatise on the Chemical Constitution of the Brain. Based Throughout upon Original Researches 1884, Bailliere Tindall and Cox, London.
152. Thurin J., Brodin T., Bechtel B., Jovall P.A., Karlsson H., Stromberg N., Teneberg S., Sjogren H.O., Karlsson K.A. Novel isoglobo-neolacto-series hybrid glycolipid detected by a monoclonal antibody is a rat: colon tumor-associated antigen. Biochim. Biophys. Acta 1989, 1002:267-272.
153. Uemura K., Yuzawa M., Taketomi T. Characterization of major glycolipids in bovine erythrocyte membrane. J. Biochem. 1978, 83:463-471.
154. Urdal D.L., Hakomori S.-I. Tumor-associated ganglio-N-triosylceramide. J. Biol. Chem. 1980, 255:10509-10516.
155. Vanier M., Svennerholm L. Chemical pathology of Krabbe disease: The occurrence of psychosine and other neutral sphingoglycolipids. Adv. Exp. Med. Biol. 1976, 68:115-126.
156. Watanabe K., Laine R.A., Hakomori S.-I. On neutral fucoglycolipids having long, branched carbohydrate chains: H-active and I-active glycosphingolipids of human erythrocyte membranes. Biochemistry 1975, 14:2725-2733.
157. Watanabe K., Matsubara T., Hakomori S.-I. α-L-Fucopyranosylceramide, a novel glycolipid accumulated in some of the human colon tumors. J. Biol. Chem. 1976, 251:2385-2387.
158. Watanabe K., Hakomori S.-I., Childs R.A., Feizi T. Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities. J. Biol. Chem. 1979, 254:3221-3228.
159. Wherrett J.R., Hakomori S.-I. Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease. J. Biol. Chem. 1973, 248:3046-3051.
160. Yasugi E., Saito E., Kasama T., Kojima H., Yamakawa T. Occurrence of 2-O-acyl galactosyl ceramide in whale brain. J. Biochem. 1982, 91:1121-1127.
161. Young W.W., Portoukalian J., Hakomori S.-I. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J. Biol. Chem. 1981, 256:10967-10972.
162. Ariga T., Kohriyama T., Freddo L., Latov N., Saito M., Kon K., Ando S., Suzuki M., Hemling M.E., Rinehart K.L., Yu R.K. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM-proteins in patients with neuropathy. J. Biol. Chem. 1987, 262:848-853.
163. Chou D.K., Iiyas A.A., Evans J.E., Costello C., Quarles R.H., Jungalwala F.B. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J. Biol. Chem. 1986, 161:11717-11725.
164. Chou D.K., Schwarting G.A., Evans J.E., Jungalwala F.B. Sulfoglucuronyl-neolacto series of glycolipids in peripheral nerves reacting with HNK-1 antibody. J. Neurochem. 1987, 49:865-873.
165. Dittmer J. The identification of cerebroside sulfate as a component of the inositol phosphatide fraction of ox brain. Bichim. Biophys. Acta 1965, 106:425-427.
166. O'Brien J.S., Rouser G. The fatty acid composition of brain sphingolipids: Sphingomyelin, ceramide, cerebroside, and cerebroside sulfate. J. Lipid Res. 1964, 5:339-342.
167. 3-bis-sulfate), associated with human heptocellular carcinoma. Cancer Res. 1988, 48:6769-6774.
168. Iida N., Toida T., Kushi Y., Handa S., Fredman P., Svennerholm L., Ishizuka I. A sulfated glucosylceramide from rat kidney. J. Biol. Chem. 1989, 264:5974-5980.
169. 3-sulfogangliotetraosylceramide, demonstrated by negative ion fast atom bombardment mass spectrometry. J. Biol. Chem. 1986, 261:1440-1444.
170. Mikami T., Tsuchihashi K., Kashiwagi M., Yachida Y., Daino T., Hashi K., Akino T., Gasa S. Characterization of a O-fatty-acylated sulfatide from equine brain. Eur. J. Biochem. 1998, 255:289-295.
171. Nagai K., Roberts D.D., Toida T., Matsumoto H., Kushi Y., Handa S., Ishizuka I. Mono-sulfated globotetraosylceramide from human kidney. J. Biochem. 1989, 106:878-886.
172. Nagai K., Roberts D.D., Toida T., Matsumoto H., Kushi Y., Handa S., Ishizuka I. Mono-sulfated globopentaosylceramide from rat kidney. J. Biol. Chem. 1989, 264:16229-16237.
173. Rosengren B., Fredman P., Mansson J.E., Svennerholm L. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain. J. Neurochem. 1989, 52:1035-1041.
174. Slomiany B.L., Slomiany A., Horowitz M.I. Sulfatides of hog gasric mucosa. Biochim. Biophys. Acta 1974, 348:388-396.
175. Slomiany B.L., Slomiany A. Isolation and characterization of the sulfated neolactotetraosylceramide from hog gastric mucosa. J. Biol. Chem. 1978, 253:3517-3520.
176. Slomiany A., Slomiany B.L., Annese C. Sulfated trihexosylceramide from gastric mucosa containing N-acetylglucosamine. Eur. J. Biochem. 1980, 109:471-474.
177. Slomiany B.L., Kojima K., Banas-Gruszka Z., Slomiany B.L. Structure of a novel sulfated sialoglycosphingolipid from bovine gastric mucosa. Biochem. Biophys. Res. Commun. 1981, 100:778-784.
178. Slomiany A., Kojima K., Banas-Gruszka Z., Murty V.L., Galicki N.I., Slomiany A. Characterization of the sulfated monosialosyltriglycosylceramide from bovine gastric mucosa. Eur. J. Biochem. 1981, 119:647-650.
179. Stoffyn A., Stoffyn P., Martensson E. Structure of kidney ceramide dihexoside sulfate. Biochim. Biophys. Acta 1968, 152:353-357.
180. Sugita M., Dulaney J.T., Moser H.W. Structure and composition of sulfatides isolated from livers of patients with metachromatic leukodystrophy: Galactosyl sulfatide and lactosyl sulfatide. J. Lipid Res. 1974, 15:227-233.
181. Tadano K., Ishizuka I. Isolation and partial characterization of a novel sulfoglycosphingolipid and ganglioside GM4 from rat kidney. Biochim. Biophys. Res. Commun. 1980, 97:126-132.
182. Tadano K., Ishizuka I. Isolation and characterization of the sulfated gangliotriaosylceramide from rat kidney. J. Biol. Chem. 1982, 257:1482-1490.
183. Tadano K., Ishizuka I. Bis-sulfoglycosphingolipid containing a unique 3-O-sulfated N-acetylgalactosamine from rat kidney. J. Biol. Chem. 1982, 257:9294-9299.
184. Tadano K., Ishizuka I., Matsuo M., Matsumoto S. Bis-sulfated gangliotetraosylceramide from rat kidney. J. Biol. Chem. 1982, 257:13413-13420.
185. Tadano-Aritomi K., Kasama T., Handa S., Ishizuka I. Isolation and structural characterization of a mono-sulfated isoglobotetraosylceramide, the first sulfoglycosphingolipid of the isoglobo-series, from rat kidney. Eur. J. Biochem. 1992, 209:305-313.
186. Tadano-Aritomi K., Okuda M., Ishizuka I., Kubo H., Ireland P. A novel mono-sulfated pentaglycosylceramide with the isoglobo-series core structure in rat kidney. Carbohydr. Res. 1994, 265:49-59.
187. Tadano-Aritomi K., Kubo H., Ireland P., Kasama T., Handa S., Ishizuka I. Structural characterization of a novel mono-sulfated gangliotriaosylceramide containing a 3-O-sulfated N-acetylgalactosamine from rat kidney. Glycoconj. J. 1996, 13:285-293.
188. Tadano-Aritomi K., Kubo H., Ireland P., Hikita T., Ishizuka I. Isolation and characterization of a unique sulfated ganglioside, sulfated GM1a, from rat kidney. Glycobiology 1998, 8:341-350.
189. Toda K., Kobayashi T., Goto I., Kurokawa T., Ogomori K. Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy. Biochem. Biophys. Res. Commun. 1989, 159:605-611.
190. Toda K., Kobayashi T., Goto I., Ohno K., Eto Y., Inui K., Okada S. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy. J. Neurochem. 1990, 55:1585-1591.
191. Yamakawa T., Kiso N., Handa S., Makita A., Yokoyama S. On the structure of brain cerebroside sulfuric ester and ceramide dihexoside of erythrocytes. J. Biochem. 1962, 52:226-227.
192. Ando S., Kon K., Isobe M., Yamakawa T. Structural study on tetraglycosyl ceremide and gangliosides isolated from human red blood cells. J. Biochem. 1973, 73:893-895.
193. Ando S., Yu R.K. Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. J. Biol. Chem. 1977, 252:6247-6250.
194. Ando S., Yu R.K. Isolation and characterization of two isomers of brain tetrasialogangliosides. J. Biol. Chem. 1979, 254:12224-12229.
195. Ando S., Hirabayashi Y., Kon K., Inagaki F., Tate S., Whittaker V.P. A trisialoganglioside containing a sialyl α2-6 N-acetylgalactosamine residue is a cholinergic-specific antigen, Chol-1α. J. Biochem. 1992, 111:287-290.
196. Ariga T., Sekine M., Yu R.K., Miyatake T. Disialogangliosides in bovine adrenal medulla. J. Biol. Chem. 1982, 257:2230-2235.
197. Ariga T., Sekine M., Nakamura K., Igarashi M., Nagashima M., Miyatake T., Suzuki A., Yamakawa T. Isolation and characterization of a novel disialoganglioside containing N-glycolylneuraminic acid from pig skeletal muscle. J. Biochem. 1983, 93:889-893.
198. Ariga T., Sekine M., Yu R.K., Miyatake T. Isolation and characterization of the trisialogangliosides from bovine adrenal medulla. J. Lipid Res. 1983, 24:737-745.
199. Ariga T., Sekine M., Yu R.K., Miyatake T. Isolation and characterization of a novel disialoganglioside from bovine adrenal medulla. Arch. Biochem. Biophys. 1984, 232:305-309.
200. Ariga T., Kobayashi K., Kuroda Y., Yu R.K., Suzuki M., Kitagawa H., Inagaki F., Miyatake T. Characterization of tumor-associated fucogangliosides from PC 12 pheochromocytoma cells. J. Biol. Chem. 1987, 262:14146-14153.
201. Ariga T., Yu R.K. Isolation and characterization of ganglioside GM1b from normal human brain. J. Lipid Res. 1987, 28:285-291.
202. Avrova N.F., Li Y.T., Obukhova E.L. On the composition and structure of individual gangliosides from the brain of elasmobranches. J. Neurochem. 1979, 32:1807-1815.
203. Bartoszewicz Z., Koscielak J., Pacuszka T. Structure of a new disialoganglioside GD1c from spontaneous murine thymoma. Carbohydr. Res. 1986, 151:77-88.
204. Blanchard D., Piller F., Gillard B., Marcus D., Cartron J.-P. Identification of a novel ganglioside on erythrocytes with blood group Cad specificity. J. Biol. Chem. 1985, 260:7813-7816.
205. Bouhours J.F., Bouhours D., Hansson G.C. Developmental changes of gangliosides of the rat stomach. Appearance of a blood group B-active ganglioside. J. Biol. Chem. 1987, 262:16370-16375.
206. x on the 6-linked antenna, and N-acetylneuraminic acidα2->3 or Galactose α1->3 on the 3-linked antenna, expressed in porcine kidney. Glycoconj. J. 1998, 15:1001-1016.
207. Breimer M.E., Hansson G.C., Karlsson K.A., Leffler H. Glycosphingolipids of rat tissues. Different composition of epithelial and nonepithelial cells of small intestine. J. Biol. Chem. 1982, 257:557-568.
208. 3Neu5AcGgOse4Cer, from bovine brain. Eur. J. Biochem. 1995, 234:786-793.
209. Chien J.L., Li S.-C., Laine R.A., Li Y.-T. Characterization of gangliosides from bovine erythrocyte membranes. J. Biol. Chem. 1978, 253:4031-4035.
210. Chien J.-L., Hogan E.L. Novel pentahexosyl ganglioside of the globo series purified from chicken muscle. J. Biol. Chem. 1983, 258:10727-10730.
211. Chigorno V., Sonnino S., Ghidoni R., Tettamanti G. Isolation and characterization of a tetrasialoganglioside from mouse brain, containing 9-O-acetyl, N-acetylneuraminic acid. Neurochem. Int. 1982, 4:531-539.
212. Chou K.H., Nolan C.E., Jungalwala F.B. Subcellular fractionation of rat sciatic nerve and specific localization of ganglioside LM1 in rat nerve myelin. J. Neurochem. 1985, 44:1898-1912.
213. Chou D.K., Flores S., Jungalwala F.B. Identification of disialosyl paragloboside and O-acetyldisialosyl paragloboside in cerebellum and embryonic cerebrum. J. Neurochem. 1990, 54:1598-1607.
214. Clausen H.K., Levery S.B., Nudelman E.D., Stroud M., Salyan M.E.K., Hakomori S.-I. Isolation and characterization of novel glycolipids with blood group A-related structures. Galactosyl-A and sialosylgalactosyl-A. J. Biol. Chem. 1987, 262:14228-14234.
215. Cochran F.B., Yu R.K., Ando S., Ledeen R.W. Myelin gangliosides: An unusual pattern in the avian central nervous system. J. Neurochem. 1981, 36:696-702.
216. Dasgupta S., Chien J.-L., Hogan E.L. N-Acetyl- and N-glycolyl neuraminosyl lacto-N-noroctasylceramides from bovine erythrocytes. Fed. Proc. (Federation of American Societies for Experimental Biology, USA) 1985, 44:1089.
217. Dasgupta S., Hogan E.L., Glushka J., van Halbeek H. Branched monosialo gangliosides of the lacto-series isolated from bovine erythrocytes: Characterization of a novel ganglioside, NeuGc-isooctaosylceramide. Arch. Biochem. Biophys. 1994, 310:373-384.
218. DeGasperi R., Koerner T.A.W., Quarles R.H., Ilyas A.A., Ishikawa Y., Li S.-C., Li Y.-T. Isolation and characterization of gangliosides with hybrid neolacto-ganglio-type sugar chains. J. Biol. Chem. 1987, 262:17149-17155.
219. Dohi T., Ohta S., Hanai N., Yamaguchi K., Oshima M. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa. J. Biol. Chem. 1990, 265:7880-7885.
220. 3LacCer) and to its 9-O-acetylated derivative. J. Biol.Chem. 1990, 265:2797-2803.
221. Felding-Habermann B., Anders A., Dippold W.G., Stallcup W.B., Wiegandt H. Melanoma-associated gangliosides in the fish genus Xiphophorus. Cancer Res. 1988, 48:3454-3460.
222. Fredman P., Mansson J.E., Svennerholm L., Samuelsson B., Pascher I., Pimlott W., Karlsson K.A., Klinghardt G.W. Chemical structures of three fucogangliosides isolated from nervous tissue of mini-pig. Eur. J. Biochem. 1981, 116:553-564.
223. Fredman P., Mansson J.-E., Wikstrand C.J., Vrionis F.D., Rynmark B.-M., Bigner D.D., Svennerholm L. A new ganglioside of the lactotetraose series, GalNAc-3′-isoLM1, detected in human meconium. J. Biol. Chem. 1989, 264:12122-12125.
224. Fredman P., Mansson J.E., Dellheden B., Bostrom K., von Holst H. Expression of the GM1-species, [NeuN]-GM1, in a case of human glioma. Neurochem. Res. 1999, 24:275-279.
225. Fukuda M.N., Dell A., Oates J.E., Wu P., Klock J.C., Fukuda M. Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. J. Biol. Chem. 1985, 260:1067-1082.
226. Fukuda M.N., Bothner B., Lloyd K.O., Rettig W.J., Tiller P.R., Dell A. Structure of glycosphingolipids isolated from human embryonal carcinoma cells. J. Biol. Chem. 1986, 261:5145-5153.
227. Fukuda M.N., Dell A., Tiller P.R., Varki A., Klock J.C., Fukuda M. Structure of a novel sialylated fucosyl lacto-N-nohexaosylceramide isolated from chronic myelogenous leukemia cells. J. Biol. Chem. 1986, 261:2376-2383.
228. 3Fuc2nLc6). J. Biol. Chem. 1984, 259:10511-10517.
229. 6NeuAcLc4) of human adenocarcinoma and the monoclonal antibody (FH9) defining this disialosyl structure. Biochemistry. 1986, 25:2859-2866.
230. Furukawa K., Chait B.T., Lloyd K.O. Identification of N-glycolylneuraminic acid-containing gangliosides of cat and sheep erythrocytes. 252Cf fission fragment ionization mass spectrometry in the analysis of glycosphingolipids. J. Biol. Chem. 1988, 263:14939-14947.
231. Gasa S., Makita A., Kinoshita Y. Further study of the chemical structure of the equine erythrocyte hematoside containing O-acetyl ester. J. Biol. Chem. 1983, 258:876-881.
232. Ghidoni R., Sonnino S., Tettamanti G., Wiegandt H., Zambotti V. On the structure of two new gangliosides from beef brain. J. Neurochem. 1976, 27:511-515.
233. Ghidoni R., Sonnino S., Tettamanti G., Baumann N., Reuter G., Schauer R. Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid. J. Biol. Chem. 1980, 255:6990-6995.
234. Gillard B.K., Blanchard D., Bouhours J.F., Cartron J.P., van Kuik J.A., Kamerling J.P., Vliegenthart J.F., Marcus D.M. Structure of a ganglioside with Cad blood group antigen. Biochemistry. 1988, 27:4601-4606.
235. Gowda D.C., Reuter G., Shukla A.K., Schauer R. Identification of a disialoganglioside (GD1a) containing terminal N-acetyl-9-O-acetylneuraminic acid in rat erythrocytes. Hoppe Seylers Z. Physiol. Chem. 1984, 365:1247-1253.
236. Guo N.H., Her G.R., Reinhold V.N., Brennan M.J., Siraganian R.P., Ginsburg V. Monoclonal antibody AA4, which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells, binds to novel α-galactosyl derivatives of ganglioside GD1b. J. Biol. Chem. 1989, 264:13267-13272.
237. Hakomori S.-I., Saito T. Isolation and characterization of a glycosphingolipid having a new sialic acid. Biochem. 1969, 8:5082-5088.
238. Hakomori S.-I., Holmes E.H., Nakayama T. A new type of glycolipid change associated with oncogenesis: A fucoganglioside accumulation in premalignant hepatic lesion and in hepatoma induced by n-2-acetylaminofluorene. Adv. Exp. Med. Biol. 1982, 152:401-413.
239. Hakomori S.-I., Nudelman E., Levery S.B., Patterson C.M. Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl α2 leads to 6 galactosyl residue: A preliminary note. Biochem. Biophys. Res. Commun. 1983, 113:791-798.
240. Hanada E., Konno K. Characterization of the lacto series of gangliosides, especially of disialo-lacto-N-norhexaosyl ceramide isolated from adult bovine nasal cartilage. J. Biochem. 1985, 97:569-577.
241. Hanai N., Nores G.A., MacLeod C., Torres-Mendez C.R., Hakomori S.-I. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 1988, 263:10915-10921.
242. Handa N., Handa S. The chemistry of lipids of posthemolytic residue or stroma of erythrocytes. XIV. Chemical structure of glycolipid of cat erythrocyte stroma. Jpn. J. Exp. Med. 1965, 35:331-341.
243. Handa S., Burton R.M. Biosynthesis of glycolipids: Incorporation of N-acetyl galactosamine by a rat brain particulate preparation. Lipids 1969, 4:589-598.
244. Hidari K.I., Irie F., Suzuki M., Kon K., Ando S., Hirabayashi Y. A novel ganglioside with a free amino group in bovine brain. Biochem. J. 1993, 296:259-263.
245. Higashi H., Ikuta K., Ueda S., Kato S., Hirabayashi Y., Matsumoto M., Naiki M. Characterization of N-glycolyneuraminic acid-containing glycosphingolipids from a Marek's disease lymphoma-derived chicken cell line, MSB1, as tumor-associated heterophile Hanganutziu-Deicher antigens. J. Biochem. 1984, 95:785-794.
246. Hirabayashi Y., Taki T., Matsumoto M. Tumor ganglioside-natural occurrence of GM1b. FEBS Lett. 1979, 100:253-257.
247. Hirabayashi Y., Li Y.T., Li S.C. Occurrence of a new hematoside in the kidney of guinea pig. FEBS Lett. 1983, 161:127-130.
248. x-active ganglioside from chick intestinal tissues recognized by murine monoclonal antibody 188C1. J. Biol. Chem. 1991, 266:10268-10274.
249. Hirabayashi Y., Nakao T., Irie F., Whittaker V.P., Kon K., Ando S. Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain. J. Biol. Chem. 1992, 267:12973-12978.
250. Hitoshi S., Kusunoki S., Kon K., Chiba A., Waki H., Ando S., Kanazawa I. A novel ganglioside, 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barre syndrome. J. Neuroimmunol. 1996, 66:95-101.
251. Holmes E.H., Hakomori S.I. Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2-acetylaminofluorene. J. Biol. Chem. 1982, 257:7698-7703.
252. Hogan E.L., Happel R.D., Chien J.-L. Membrane glycosphingolipids in chicken muscular dystrophy. Adv. Exp. Med. Biol. 1982, 152:273-278.
253. Ishizuka I., Wiegandt H. An isomer of trisialoganglioside and the structure of tetra- and pentasialogangliosides from fish brain. Biochim. Biophys. Acta 1972, 260:279-289.
254. Irie F., Kurono S., Li Y.T., Seyama Y., Hirabayashi Y. Isolation of three novel cholinergic neuron-specific gangliosides from bovine brain and their in vitro syntheses. Glycoconj. J. 1996, 13:177-186.
255. Ito A., Levery S.B., Saito S., Satoh M., Hakomori S.-I. A novel ganglioside isolated from renal cell carcinoma. J. Biol. Chem. 2001, 276:16695-16703.
256. Itoh T., Li Y.T., Li S.C., Yu R.K. Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain. J. Biol. Chem. 1981, 256:165-169.
257. Iwamori M., Nagai Y. Isolation and characterization of GD3 ganglioside having a novel disialosyl residue from rabbit thymus. J. Biol. Chem. 1978, 253:8328-8331.
258. Iwamori M., Nagai Y. Isolation and characterization of a novel ganglioside, monosialosyl pentahexaosyl ceramide from human brain. J. Biochem. 1978, 84:1601-1608.
259. Iwamori M., Nagai Y. Ganglioside-composition of brain in Tay-Sachs disease: Increased amounts of GD2 and N-acetyl-β-D-galactosaminyl GD1a ganglioside. J. Neurochem. 1979, 32:767-777.
260. Iwamori M., Nagai Y. Monosialogangliosides of rabbit skeletal muscle. Characterization of N-acetylneuraminosyl lacto-N-noroctaosyl ceramide. J. Biochem. 1981, 89:1253-1264.
261. Iwamori M., Noguchi M., Yamamoto T., Yago M., Nozawa S., Nagai Y. Selective terminal α2-3 and α2-6 sialylation of glycosphingolipids with lacto series type 1 and 2 chains in human meconium. FEBS Lett. 1988, 233:134-138.
262. Kannagi R., Roelcke D., Peterson K.A., Okada Y., Levery S.B., Hakomori S.-I. Characterization of an epitope (determinant) structure in a developmentally regulated glycolipid antigen defined by a cold agglutinin Fl, recognition of α-sialosyl and α-L-fucosyl groups in a branched structure. Carbohydr. Res. 1983, 120:143-157.
263. Kannagi R., Levery S.B., Ishigami F., Hakomori S.-I., Shevinsky L.H., Knowles B.B., Solter D. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J. Biol. Chem. 1983, 258:8934-8942.
264. a structure from a human rectal adenocarcinoma. J. Biol. Chem. 1993, 268:26541-26545.
265. Klenk E., Lauenstein I. [Glycolipids and sphingomyelins in the stroma of horse erythrocytes]. Hoppe Seylers Z. Physiol. Chem. 1953, 295:164-173.
266. Klenk E., Naoi M. [On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase]. Hoppe Seylers Z. Physiol. Chem. 1968, 349:288-292.
267. Klenk E., Gielen W. [On a 2d hexose-containing ganglioside from human brain]. Hoppe Seylers Z. Physiol. Chem. 1963, 330:218-226.
268. Kniep B., Claus C., Peter-Katalinic J., Monner D.A., Dippold W., Nimtz M. 7-O-acetyl-GD3 in human T-lymphocytes is detected by a specific T-cell-activating monoclonal antibody. J. Biol. Chem. 1995, 270:30173-30180.
269. Kuhn R., Wiegandt H. [The constitution of gangliosides G-II, G-III and G-IV]. Z. Naturforsch B. 1963, 18:541-543.
270. Kundu S.K., Samuelsson B.E., Pascher I., Marcus D.M. New gangliosides from human erythrocytes. J. Biol. Chem. 1983, 258:13857-13866.
271. Kushi Y., Shimizu M., Watanabe K., Kasama T., Watarai S., Ariga T., Handa S. Characterization of blood group ABO(H)-active gangliosides in type AB erythrocytes and structural analysis of type A-active ganglioside variants in type A human erythrocytes. Biochim. Biophys. Acta 2001, 1525:58-69.
272. 6NeuAcLc4Cer in human SW1116 colorectal carcinoma cells: A possible oncofetal antigen that is not dependent on Lewis gene expression. Arch. Biochem. Biophys. 1987, 258:315-323.
273. Ledeen R., Salsman K., Gonatas J., Taghavy A. Structure comparison of the major monosialogangliosides from brains of normal human, gargoylism, and late infantile systemic lipidosis. I. J. Neuropathol. Exp. Neurol. 1965, 24:341-351.
274. Ledeen R.W., Salsman K., Cabrera M. Gangliosides of bovine adrenal medulla. Biochemistry 1968, 7:2287-2295.
275. Ledeen R.W., Yu R.K., Eng L.F. Gangliosides of human myelin: Sialosylgalactosylceramide (G7) as a major component. J. Neurochem. 1973, 21:829-839.
276. 3FucnLc6Cer). Carbohydr. Res. 1988, 178:121-144.
277. Levery S.B., Nudelman E.D., Salyan M.E., Hakomori S.-I. Novel tri- and tetrasialosylpoly-N-acetyllactosaminyl gangliosides of human placenta: Structure determination of pentadeca- and eicosaglycosylceramides by methylation analysis, fast atom bombardment mass spectrometry, and 1HNMR spectroscopy. Biochemistry 1989, 28:7772-7781.
278. Levery S.B., Salyan M.E., Steele S.J., Kannagi R., Dasgupta S., Chien J.L., Hogan E.L., van Halbeek H., Hakomori S.-I. A revised structure for the disialosyl globo-series gangliosides of human erythrocytes and chicken skeletal muscle. Arch. Biochem. Biophys. 1994, 312:125-134.
279. Li Y.T., Mansson J.E., Vanier M.T., Svennerholm L. Structure of the major glucosamine-containing ganglioside of human tissues. J. Biol. Chem. 1973, 248:2634-2636.
280. Li S.C., Chien J.L., Wan C.C., Li Y.T. Occurrence of glycosphingolipids in chicken egg yolk. Biochem. J. 1978, 173:697-699.
281. Li Y.T., Maskos K., Chou C.-W., Cole R.B., Li S.-C. Presence of an usual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain. J. Biol. Chem. 2003, 278:35286-35291.
282. Macher B.A., Buehler J., Scudder P., Knapp W., Feizi T. A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2. J. Biol. Chem. 1988, 263:10186-10191.
283. Magnani J.L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem. 1982, 257:14365-14369.
284. Mansson J.E., Fredman P., Nilsson O., Lindholm L., Holmgren J., Svennerholm L. Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma. Biochim. Biophys. Acta 1985, 834:110-117.
285. Mansson J.E., Fredman P., Bigner D.D., Molin K., Rosengren B., Friedman H.S., Svennerholm L. Characterization of a new gangliosides of the lactoteraose series in murine xenografts of a human glioma cell line. FEBS Lett. 1986, 201:109-113.
286. Matsumoto M., Taki T., Samuelsson B., Pascher I., Hirabayashi Y., Li S.C., Li Y.-T. Further characterization of the structure of GM1b ganglioside from rat ascites hepatoma. J. Biol. Chem. 1981, 256:9737-9741.
287. Miller-Podraza H., Mansson J.E., Svennerholm L. Pentasialogangliosides of human brain. FEBS Lett. 1991, 288:212-214.
288. Miller-Podraza H., Lanne B., Angstrom J., Teneberg S., Milh M.A., Jovall P.-A., Karlsson H., Karlsson K.-A. Novel binding epitope for Helicobacter pylori found in neolacto carhohydrate chains. Structure and cross-binding properties. J. Biol. Chem. 2005, 280:19695-19703.
289. Molin K., Mansson J.E., Fredman P., Svennerholm L. Sialosyllactotetraosylceramide, 3′-isoLM1, a ganglioside of the lactotetraose series isolated from normal human infant brain. J. Neurochem. 1987, 49:216-219.
290. Murakami-Murofushi K., Tadano K., Koyama I., Ishizuka I. A trisialosyl ganglioside GT3 of hog kidney. Structure and biosynthesis in vitro. J. Biochem. 1981, 90:1817-1820.
291. 3nLcOse4Cer, from hog kidney cortex. J. Biochem. 1983, 93:621-629.
292. Murayama K., Levery S.B., Schirrmacher V., Hakomori S.-I. Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1α) from Eb cells. Carbohydr. Res. 1986, 46:1395-1402.
293. Muthing J., Egge H., Kniep B., Muhlradt P.F. Structural characterization of gangliosides from murine T lymphocytes. Eur. J. Biochem. 1987, 163:407-416.
294. Muthing J., Spanbroek R., Peter-Katalinic J., Hanisch F.G., Hanski C., Hasegawa A., Unland F., Lehmann J., Tschesche H., Egge H. Isolation and structural characterization of fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes. Glycobiology 1996, 6:147-156.
295. Nakamura K., Hashimoto Y., Suzuki M., Suzuki A., Yamakawa T. Characterization of GM1b in mouse spleen. J Biochem. 1984, 96:949-957.
296. Nakamura K., Suzuki M., Inagaki F., Yamakawa T., Suzuki A. A new ganglioside showing choleragenoid-binding activity in mouse spleen. J. Biochem. 1987, 101:825-835.
297. Nakamura K., Inagaki F., Tamai Y. A novel ganglioside in dogfish brain. Occurrence of a trisialoganglioside with a sialic acid linked to N-acetylgalactosamine. J. Biol. Chem. 1988, 263:9896-9900.
298. 3 α(NeuGc α2-8NeuGc)-Gg4Cer, is a major disialoganglioside in WHT/Ht mouse thymoma and thymocytes. J. Biochem. 1991, 110:832-841.
299. Nakamura K., Tamai Y., Kasama T. Gangliosides of dogfish (Squalus acanthias) brain. Neurochem. Int. 1997, 30:593-604.
300. Nakamura K., Kojima H., Suzuki M., Suzuki A., Tamai Y. Novel polysialogangliosides of skate brain structural determination of tetra- penta- and hexasialogangliosides with a NeuAc-GalNAc linkage. Eur. J. Biochem. 2000, 267:5198-5208.
301. Nakao T., Kon K., Ando S., Hirabayashi Y. A NeuGc-containing trisialoganglioside of bovine brain. Biochim. Biophys. Acta 1991, 1086:305-309.
302. Nakao T., Kon K., Ando S., Miyatake T., Yuki N., Li Y.-T., Furuya S., Hirabayashi Y. Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder. J. Biol. Chem. 1993, 268:21028-21034.
303. 3-Neu5Ac-gangliotriaosylsphingosine) in GM2 gangliosidosis brain. Biol. Chem. Hoppe Seyler. 1986, 367:241-244.
304. Niimura Y., Tomori M., Tadano-Aritomi K., Toida T., Ishizuka I. The major acidic glycolipids from the kidney of the Pacific salmon (Oncorhynchus keta): Characterization of a novel ganglioside, fucosyl-N-acetylgalactosaminyl-GM1. J. Biochem. 1999, 126:962-968.
305. Nilsson O., Mansson J.E., Lindholm L., Holmgren J., Svennerholm L. Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody. FEBS Lett. 1985, 182:398-402.
306. Nohara-Uchida K., Ohashi M. Isolation and characterization of major gangliosides from frog liver. J. Biochem. 1987, 102:923-932.
307. Nohara K., Suzuki M., Inagaki F., Ito H., Kaya K. Identification of novel gangliosides containing lactosaminyl-GM1 structure from rat spleen. J.Biol. Chem. 1990, 265:14335-14339.
308. Nohara K., Suzuki M., Inagaki F., Ito H., Kaya K. A unique fucoganglioside with blood group B determinant in rat spleen. J. Biochem. 1990, 108:684-688.
309. Nohara K., Suzuki M., Inagaki F., Kaya K. A GM1b-derived disialoganglioside GD1c is the predominant ganglioside of rat thymocytes. J. Biochem. 1991, 110:274-278.
310. Nohara K., Suzuki M., Inagaki F., Sano T., Kaya K. A novel disialoganglioside in rat spleen lymphocytes. J. Biol. Chem. 1992, 267:14982-14986.
311. Nores G.A., Dohi T., Taniguchi M., Hakomori S.-I. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: Requirements for tumor-associated antigen and immunogen. J. Immunol. 1987, 139:3171-3176.
312. 2 lactosyl Cer), and related compounds. Carbohydr. Res. 1988, 179:393-410.
313. 3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J. Biol. Chem. 1986, 261:5487-5495.
314. Nudelman E.D., Mandel U., Levery S.B., Kaizu T., Hakomori S.-I. A series of disialogagliosides with binary 2-3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens. J. Biol. Chem. 1989, 264:18719-18725.
315. Ohashi M., Yamakawa T. Isolation and characterization of glycosphingolipids in pig adipose tissue. J. Biochem. 1977, 81:1675-1690.
316. Ohashi M. A new type of ganglioside. The structures of three novel gangliosides from fat body of the frog. J. Biochem. 1980, 88:583-589.
317. Ohashi M. A new type of ganglioside: Carbohydrate structures of the major gangliosides from frog brain 1981, 33-34. Japan Scientific Societies Press, Tokyo, Japan. T. Yamakawa, T. Osawa, S. Handa (Eds.).
318. Ostrander G.K., Levery S.B., Hakomori S.-I., Holmes E.H. Isolation and characterization of the major acidic glycosphingolipids from the liver of the English sole (Parophrys vetulus). Presence of a novel ganglioside with a Forssman antigen determinant. J. Biol. Chem. 1988, 263:3103-3110.
319. Pacuszka T., Antoniewicz J. A novel form of GD1c ganglioside IV3 (NeuAc α2-8 NeuGc)Gg4Cer from murine X-ray induced thymoma. Acta Biochim. Pol. 1988, 35:387-393.
320. Price H., Kundu S., Ledeen R. Structures of gangliosides from bovine adrenal medulla. Biochemistry 1975, 14:1512-1518.
321. Prieto P.A., Smith D.F. A new ganglioside in human meconium detected by antiserum against the human milk sialyloligosaccharide, LS-tetrasaccharide b. Arch. Biochem. Biophys. 1985, 241:281-289.
322. Prieto P.A., Smith D.F. A new ganglioside in human meconium detected with antiserum against human milk sialyltetrasaccharide a. Arch. Biochem. Biophys. 1986, 249:243-253.
323. Rauvala H. Gangliosides of human kidney. J. Biol. Chem. 1976, 251:7517-7520.
324. Rauvala H., Krusius T., Finne J. Disialosyl paragloboside. A novel ganglioside isolated from human kidney. Biochim. Biophys. Acta 1978, 531:266-279.
325. Ren S., Scarsdale J.N., Ariga T., Zhang Y., Klein R.A., Hartmann R., Kushi Y., Egge H., Yu R.K. O-acetylated gangliosides in bovine buttermilk. Characterization of 7-O-acetyl, 9-O-acetyl, and 7,9-di-O-acetyl GD3. J. Biol. Chem. 1992, 267:12632-12638.
326. Ren S., Ariga T., Scarsdale J.N., Zhang Y., Slominski A., Livingston P.O., Ritter G., Kushi Y., Yu R.K. Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3. J. Lipid Res. 1993, 34:1565-1572.
327. Riboni L., Sonnino S., Acquotti D., Malesci A., Ghidoni R., Egge H., Mingrino S., Tettamanti G. Natural occurrence of ganglioside lactones. Isolation and characterization of GD1b inner ester from adult human brain. J. Biol. Chem. 1986, 261:8514-8519.
328. Rizzo A.M., Berra B., Rossi F., Guerra A., Gornati R., Bernardini G., Taki T., Kasama T., Mauri L., Sonnino S. Structure of the main ganglioside from the brain of Xenopus laevis. Glycoconj. J. 2002, 19:53-57.
329. Ritter G., Boosfeld E., Markstein E., Yu R.K., Ren S.L., Stallcup W.B., Oettgen H.F., Old L.J., Livingston P.O. Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3. Cancer Res. 1990, 50:1403-1410.
330. Saito M., Kitamura H., Sugiyama K. Liver gangliosides of various animals ranging from fish to mammalian species. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 2001, 129:747-758.
331. Saito M., Kitamura H., Sugiyama K. A novel heptasialosyl c-series ganglioside in embryonic chicken brain: Its structure and stage-specific expression. Biochim. Biophys. Acta 2002, 1571:18-26.
332. Sekine M., Nakamura K., Suzuki M., Inagaki F., Yamakawa T., Suzuki A. A single autosomal gene controlling the expression of the extended globoglycolipid carrying SSEA-1 determinant is responsible for the expression of two extended globogangliosides. J. Biochem. 1988, 103:722-729.
333. Schwarting G.A., Carroll P.G., DeWolf W.C. Fucosyl-globoside and sialosyl-globoside are new glycolipids isolated from human teratocarcinoma cells. Biochem. Biophys. Res. Commun. 1983, 112:935-940.
334. Seyfried T.N., Ando S., Yu R.K. Isolation and characterization of human liver hematoside. J. Lipid Res. 1978, 19:538-543.
335. Shimamura M., Oku M., Yamagata T. A novel ganglioside expressed by mouse hematopoietic cell line. J. Biol. Chem. 1992, 267. 18810-18813.
336. Sjoberg E.R., Manzi A.E., Khoo K.H., Dell A., Varki A. Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells. J. Biol. Chem. 1992, 267:16200-16211.
337. Sjoberg E.R., Chammas R., Ozawa H., Kawashima I., Khoo K.-H., Morris H.R., Dell A., Tai T., Varki A. Expession of de-N-acetyl-gangliosides in human melanoma cells is induced by genistein or nocodazole. J. Biol. Chem. 1995, 270:2921-2930.
338. Song Y., Kitajima K., Inoue S., Inoue Y. Isolation and structural elucidation of a novel type of ganglioside, deaminated neuraminic acid (KDN)-containing glycosphingolipid, from rainbow trout sperm. J. Biol. Chem. 1991, 266:21929-21935.
339. Song Y., Kitajima K., Inoue S., Muto Y., Kasama T., Handa S., Inoue Y. Structure of novel gangliosides, deaminated neuraminic acid (KDN)-containing glycosphingolipids, isolated from rainbow trout ovarian fluid. Biochemistry 1993, 32:9221-9229.
340. Song Y., Kitajima K., Inoue S., Khoo K.H., Morris H.R., Dell A., Inoue Y. Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification. Glycobiology 1995, 5:207-218.
341. Sonnino S., Ghidoni R., Galli G., Tettamanti G. On the structure of a new, fucose-containing ganglioside from pig cerebellum. J. Neurochem. 1978, 31:947-956.
342. Suzuki A., Ishizuka I., Yamakawa T. Isolation and characterization of a ganglioside containing fucose from boar testis. J. Biochem. 1975, 78:947-954.
343. Svennerholm L., Mansson J.E., Li Y.-T. Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain. J. Biol. Chem. 1973, 248:740-742.
344. Takamizawa K., Iwamori M., Mutai M., Nagai Y. Gangliosides of bovine buttermilk. Isolation and characterization of a novel monosialoganglioside with a new branching structure. J. Biol. Chem. 1986, 261:5625-5630.
345. Taki T., Hirabayashi Y., Ishikawa H., Ando S., Kon K., Tanaka Y., Matsumoto M. A ganglioside of rat ascites hepatoma AH 7974F cells. Occurrence of a novel disialoganglioside (GD1α) with a unique N-acetylneuraminosyl (α2-6)-N-acetylgalactosamine structure. J. Biol. Chem. 1986, 261:3075-3078.
346. Taki T., Matsuo K., Yamamoto K., Matsubara T., Hayashi A., Abe T., Matsumoto M. Human placenta gangliosides. Lipids 1988, 23:192-198.
347. Taki T., Rokukawa C., Kasama T., Handa S. Human hepatoma gangliosides: Occurrence of a novel I-type glycolipid with NeuAc α2-6Gal structure. Cancer Res. 1992, 52:4805-4811.
348. Taki T., Rokukawa C., Kasama T., Kon K., Ando S., Abe T., Handa S. Human meconium gangliosides. Characterization of a novel I-type ganglioside with the NeuAc α2-6Gal structure. J. Biol. Chem. 1992, 267:11811-11817.
349. Terabayashi T., Kawanishi Y. Naturally occurring ganglioside lactones in Minke whale brain. Carbohydr. Res. 1998, 307:281-290.
350. Thurin J., Herlyn M., Hindsgaul O., Stromberg N., Karlsson K.A., Elder D., Steplewski Z., Koprowski H. Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. J. Biol. Chem. 1985, 260:14556-14563.
351. Waki H., Murata A., Kon K., Maruyama K., Kimura S., Ogura H., Ando S. Isolation and characterization of a trisialyllactosylceramide, GT3 containing an O-acetylated sialic acid in cod fish brain. J. Biochem. 1993, 113:502-507.
352. Waki H., Masuzawa A., Kon K., Ando S. A new O-acetylated trisialylganglioside, 9-O-acetyl GT2, in cod brain. J. Biochem. 1993, 114:459-462.
353. Watanabe K., Powell M., Hakomori S.-I. Isolation and characterization of a novel fucoganglioside of human erythrocyte membranes. J. Biol. Chem. 1978, 253:8962-8967.
354. Watanabe K., Powell M.E., Hakomori S.-I. Isolation and characterization of gangliosides with a new sialosyl linkage and core structures. II. Gangliosides of human erythrocyte membranes. J. Biol. Chemistry 1979, 254:8223-8229.
355. Watanabe K., Hakomori S.-I. Gangliosides of human erythrocytes. A novel ganglioside with a unique N-acetylneuraminosyl-(2 leads to 3)-N-acetylgalactosamine structure. Biochemistry 1979, 18:5502-5504.
356. Wherrett J.R. Characterization of the major ganglioside in human red cells and of a related tetrahexosyl ceramide in white cells. Biochim. Biophys. Acta 1973, 326:63-73.
357. Wiegandt H. Gangliosides of extraneural organs. Hoppe Seylers Z. Physiol. Chem. 1973, 354:1049-1056.
358. Wiegandt H. Monosialo-lactoisohexaosyl-ceramide: A ganglioside from human spleen. Eur. J. Biochem. 1974, 45:367-369.
359. Wieruszeski J.M., Chekkor A., Bougnelet S., Montreuil J., Strecker G., Peter-Katalinic J., Egge H. Structure of two new oligosaccharides isolated from human milk: Sialylated lacto-N-fucopentaoses I and II. Carbohydr. Res. 1985, 137:127-138.
360. Wikstrand C.J., He X.M., Fuller G.N., Bigner S.H., Fredman P., Svennerholm L., Bigner D.D. Occurrence of lacto series ganglioside 3′-isoLM1 and 3′,6′-isoLD1 in human gliomas in vitro and in vivo. J. Neuropathol. Exp. Neurol. 1991, 50:756-769.
361. Yachida Y., Tsuchihashi K., Gasa S. Characterization of novel mono-O-acetylated GM3s containing 9-O-acetyl sialic acid and 6-O-acetyl galactose in equine erythrocytes. Glycoconj. J. 1996, 13:225-233.
362. Yachida Y., Tsuchihashi K., Gasa S. Novel di-O-acetylated GM3s from equine erythrocytes, one containing 4,9-di-O-acetyl-N-glycoylneuraminic acid and another containing 4-O-acetyl-N-glycolylneuraminic acid and 6-O-actyl-D-galactose. Carbohydr. Res. 1997, 298:201-212.
363. Yamakawa T., Suzuki S. The chemistry of lipids of posthemolytic residue or storoma of erythrocytes. I. Concerning the ether-insoluble lipids of lyophilized horse blood stroma. J. Biochem. 1951, 38:199-212.
364. Yamamoto H., Iida-Tanaka N., Kasama T., Ishizuka I., Kushi Y., Handa S. Isolation and characterization of a novel Forssman active acidic glycosphingolipid with branched isoglobo-, ganglio-, and neolacto-series hybrid sugar chains. J. Biochem. 1999, 125:923-930.
365. Yu R.K., Ando S. Structures of some new complex gangliosides of fish brain. Adv. Exp. Med. Biol. 1980, 125:33-45.
366. Yu R.K., Itoh T., Yohe H.C., Macala L.J. Characterization of some minor gangliosides in Tay-Sachs brains. Brain Res. 1983, 275:47-52.